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Background Although it is well recognized that the
diagnosis of hypertension should be based on blood
pressure (BP) measurements taken on several occasions,
notably to account for a transient elevation of BP on the
first readings, the prevalence of hypertension in
populations has often relied on measurements at a single
visit.
Objective To identify an efficient strategy for assessing
reliably the prevalence of hypertension in the population
with regards to the number of BP readings required.
Design Population-based survey of BP and follow-up
information.
Setting and participants All residents aged 25–64 years
in an area of Dar es Salaam (Tanzania).
Main outcome measures Three BP readings at four
successive visits in all participants with high BP (n 653)
and in 662 participants without high BP, measured with an
automated BP device.
Results BP decreased substantially from the first to third
readings at each of the four visits. BP decreased
substantially between the first two visits but only a little
between the next visits. Consequently, the prevalence of
high BP based on the third reading – or the average of the
second and third readings – at the second visit was not
largely different compared to estimates based on readings
at the fourth visit. BP decreased similarly when the first
three visits were separated by 3-day or 14-day intervals.
Conclusions Taking triplicate readings on two visits,
possibly separated by just a few days, could be a minimal
strategy for assessing adequately the mean BP and the
prevalence of hypertension at the population level. A
sound strategy is important for assessing reliably the
burden of hypertension in populations. J Hypertens
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Introduction
While the relationship between blood pressure (BP)
and adverse health effects is clearly continuous [1,2],
decision-making for clinical treatment relies on a
dichotomic classification of people into ‘normotensive’
and ‘hypertensive’. Dichotomous classification is com-
plicated by the large variability in BP measurements
over repeated readings [3–5], which relates, among
other factors, to a transient elevation of BP associated
with an alarm reaction among individuals submitted to
BP measurement [6]. Hence, estimates of BP based on
readings taken on several successive visits better repre-
sent a patient’s usual BP level [7,8]. For example,
duplicate readings over five visits were found to esti-
mate reliably 24-h ambulatory BP [9]. A study in 271
healthy persons submitted to 14 subsequent readings at
two separate visits showed that BP further decreased up
to the eighth reading on each of the two visits and later
readings better represented BP at rest [10].
The need to base the diagnosis of hypertension on
several BP readings made at several visits is empha-
sized in the current recommendations for clinical prac-
tice. The American JNCVI recommendations state that
hypertension should be diagnosed on the basis of the
average of two or more readings at each of two or more
visits after an initial screening visit and that additional
readings should be obtained at each visit if the first two
readings differ by . 5 mmHg [11]. The British Hyper-
tension Society recommends performing two or more
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readings at each visit on up to four separate occasions
[12]. The WHO/ISH guidelines recommend diagnosing
hypertension based on multiple pressure measure-
ments, taken on several separate occasions [13].
Despite the recognition that BP estimates based on
readings at a first visit are likely to overestimate a
person’s true BP, the diagnosis of ‘hypertension’ has
relied on only one or two readings at a single screening
visit in most epidemiological studies, although a few
have relied on repeated readings over two visits [14–
17]. The prevalence of hypertension in epidemiologic
studies is likely to be overestimated if it is based on too
few readings/visits while multiplying the number of
visits can substantially increase the costs and inconve-
niences for individuals and health services. In addition,
the variability of BP over repeated readings may differ
between different populations and this issue should
therefore be examined in various settings to guide
sound recommendations for the diagnosis of hyper-
tension.
We therefore examined, in a large sample of the
general population of a low-income country, the varia-
bility of BP over triplicate BP readings made at each of
four successive visits in order to identify an efficient
strategy for assessing hypertension reliably at the popu-
lation level. This is, to our knowledge, the first popu-
lation-based study to address this issue in a low-income
country. We also examined if the decrease in BP over
repeated readings differed if the first visits took place
at 3-day or 14-day intervals. Finally, we examined if
this decrease was associated with a few selected
participants’ characteristics.
Methods
Dar es Salaam, with over 3 million inhabitants, is the
economic center of Tanzania. The Republic of Tanza-
nia is situated on the east coast of Africa, south of
Kenya and north of Mozambique. The gross national
product per capita of Tanzania was US$ 220 in 1999
and total health expenditures amounted to only US$ 12
per capita compared with US$ 1600–3600 in Western
European countries [18].
The study took place in five branches of the Temeke
district of Dar es Salaam, an area where the population
has been enumerated as part of another research
program [19,20]. First, a survey of blood pressure and
other cardiovascular risk factors was carried out from
November 1998 to August 1999. Seventeen local clin-
ical officers visited all homes in the study area and they
administered a questionnaire and measured BP and
anthropometric variables in all encountered residents
aged 25–64 years. The visits in the field were facili-
tated by ‘ten-cell leaders’, i.e. the community leaders
who administer clusters of ‘10 adjacent houses’ (‘shi-
nas’) and know personally the 100–200 residents living
in their respective constituencies. The survey gathered
a participation of 9254 (62.2%) of the eligible 14 866
inhabitants aged 25–64 years living in the study area.
Methods of the survey, participants’ characteristics and
the distribution of BP and other risk factors have been
reported [21].
All participants who had, on the first BP reading of the
survey, systolic BP > 160 mmHg and/or diastolic BP >
95 mmHg and/or were under antihypertension treat-
ment were invited to have their BP measured on three
additional visits (these persons are referred as ‘cases’ in
this paragraph). For each case included in the follow-up
study, a participant with BP , 160/95 mmHg, on the
first reading of the survey, and not taking antihyperten-
sion treatment was selected to also have BP measured
on three additional visits (‘controls’). A control was
selected immediately after a case was identified and
was matched for age ( 10 years), sex and household
area. All cases and controls were allocated alternatively
to a ‘cohort A’ or a ‘cohort B’. BP readings were
scheduled to take place 3, 6 and 45 days after the first
visit in cohort A and 14, 28 and 45 days after the first
visit in cohort B. Participants who had diastolic
BP > 120 mmHg on the third BP at the first visit
(survey) were referred to health services and not
included in this study (42 of the 9254 participants to
the survey). No intervention was provided before the
last reading at the fourth visit. The study was approved
by the Tanzanian National Institute of Medical Re-
search and by the Tanzanian Commission for Science
and Technology. All participants were informed that
the study aimed at assessing the prevalence of high BP
in the population and were free to participate.
Humeral BP was measured on the left arm with a
validated automatic device (Visomat 2; Hestia Pharma,
Mannheim, Germany) [22] with subjects in a sitting
position. Triplicate readings were made at each of the
four visits (i.e. the survey and three follow-up visits).
We hereafter use the notation VxRy to designate a
reading at a specific visit/reading. For example, V1R1
designates the first reading at the first visit and V4R23
designates the average of the second and third readings
at the fourth visit. All measurements were made at the
participants’ homes. The first reading was measured
after a rest of > 5 min and the subsequent readings
were taken at intervals of > 2 min. Weight was meas-
ured with a portable electronic scale at a 0.1 kg preci-
sion (Planax Automatic ST 500; Terraillon, Paris,
France) and height was measured with a portable
stadiometer at a 0.5 cm precision. Body mass index
(BMI) was calculated as weight divided by height
squared (kg/m2). A wealth score ranging from 0 to 5
was based on the answers to five questions (coded as 0
for ‘no’ and 1 for ‘yes’): availability at home of
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electricity (reported by 58.1% of respondents in this
study), refrigerator (29.3%), television (24.9%), flush
toilet (15.6%) and car (5.8%).
The mean BP values and 95% confidence intervals
(95% CI) and the prevalence of high BP were calcu-
lated for each visit/reading. Correlation coefficients be-
tween successive BP readings were computed to
indicate the variability in repeated BP readings at the
individual level. Multivariate linear regression was
performed to examine the associations between the
proportionate decrease in BP over repeated readings
and selected variables. Interactions effects were evalu-
ated among variables with a significant main effect.
Analyses were performed with Stata 7.0 (Stata Corpora-
tion, College Station, Texas, USA). P values less than
0.05 were considered significant.
Results
This follow-up study was attended by 653 cases
(mean  SD age: 46.3  8 years, 33% male, 19% on
hypertension medication) and 662 controls (37.8 
8 years, 29% male), hence a total of 1315 participants.
This number does not include 148 persons who partici-
pated in the survey but were lost to follow-up. Cohort
A included 658 participants (325 cases and 333 controls)
and Cohort B included 657 participants (328 cases and
329 controls).
The intervals (mean  SD) between the first and
second visits were 3.0  0.2 days in cohort A and
13.9  0.7 days in cohort B; 3.2  1.1 and 14.0  0.7
days between the second and third visits; and 38.6 
2.6 and 17.0  0.9 days between the third and fourth
visits. Mean systolic/diastolic BP was not significantly
different, for any of the 12 readings (i.e. V1R1, V1R2,
V1R3, V2R1, . . ., V4R3), when comparing BP between
participants of cohort A and cohort B (data not shown,
available from authors). Therefore, the variability of BP
over subsequent visits was analyzed based on pooled
data from cohorts A and B.
Table 1 shows selected characteristics of the partici-
pants by BP categories. Hypertensive subjects were
older than non-hypertensive persons. Approximately
one-third of the participants were men. BP on V1R1
differed largely compared to the V4R3 in the three BP
groups. Participants under antihypertension treatment
were markedly more well off than other participants.
This may indicate a selection bias: wealthy persons
may be more likely than other persons, in this low-
income population, to undergo screening for hyper-
tension and/or afford the costs of antihypertension
treatment. Wealthier persons also smoked less often,
had higher body mass index, and reported more often
to be diabetic.
Correlation coefficients between readings within same
visits ranged from 0.82 to 0.93. Correlation coefficients
between readings across different visits ranged from
0.68 to 0.83. When BP was based on the average of two
readings (R12 or R23) or three readings (R123) at a
same visit, the correlation coefficients between esti-
mates at different visits ranged from 0.72 to 0.87. All
coefficients were statistically significant. The magni-
tude of these correlation coefficients was only ‘fair’,
which indicates substantial variability in repeated BP
readings in same individuals.
Because participants under treatment can differ from
other participants with respect to previous exposure to
BP measurement, we examined the BP decrease over
repeated visits/readings separately in participants, at
V1R1, with BP > 160/95 mmHg and not under antihy-
pertension treatment (Group I), participants under
antihypertension treatment (Group II) and participants
with BP , 160/95 mmHg and not under antihyperten-
sion treatment (Group III). Figure 1 shows that systolic
and diastolic mean BP decreased substantially over
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 1 Selected characteristics of the participants
BP at V1R1 > 160/
95 mmHg and no
treatment
Under
antihypertension
treatment
BP at V1R1 , 160/
95 mmHg and no
treatment All participants
n 524 129 662 1315
Age (years) 46.0  10.6 47.4  11.4 37.7  8.8 41.9  10.7
Proportion of men (%) 35.9 25.6 29.2 31.5
Body mass index (kg/m2) 25.9  5.5 28.4  5.1 24.4  5.0 25.4  5.4
Smoking cigarettes daily (%) 12.4 6.2 8.8 10.0
Reporting to be diabetic (%) 1.7 5.5 1.2 1.8
Systolic BP at V1R1 (mmHg) 161.1  20.7 149.8  23.4 120.2  16.0 139.4  27.1
Systolic BP at V4R3 (mmHg) 139.5  20.3 135.6  23.7 110.7  13.7 124.6  22.6
Diastolic BP at V1R1 (mmHg) 101.5  11.1 90.8  16.3 74.4  11.3 86.8  17.4
Diastolic BP at V4R3 (mmHg) 88.9  14.6 84.9  16.2 68.9  11.0 78.4  16.3
Electricity at home (%) 52.9 78.3 58.2 58.1
Refrigerator at home (%) 23.5 51.2 29.7 29.3
Car in household (%) 4.4 14.0 5.3 5.8
V1R1: first reading at first visit; V4R3: third reading at fourth visit. BP, blood pressure.
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repeated readings both within and between visits
among the three groups of participants. The within-
visit decrease (i.e. V1R1–V1R3, V2R1–V2R3, etc) was
of a similar magnitude at each of the four visits in the
three groups. This decrease was significant in Group I
and Group III (95% CI on the figure do not overlap)
but only marginally significant in Group II (wider 95%
CI due to the small number of participants under
treatment). The between-visit decrease (i.e. V1R1–
V2R1, V2R1–V3R1, V3R1–V4R1) was substantial be-
tween the first and the second visits but smaller be-
tween subsequent visits.
As a consequence, the proportionate difference in
systolic/diastolic BP between the first reading at the
first visit and the third reading at the second visit
(V1R1–V2R3) was approximately 80% of the difference
in systolic/diastolic BP between the first reading at the
first visit and the third reading at the fourth visit
(V1R1–V4R3) in the three groups of participants (‘ra-
tio’, Table 2).
Figure 2 shows that among the participants with high
BP based on V1R1 (BP > 160/95 mmHg, with or with-
out treatment), as few as 48% had high BP based on
V2R3 and 43% had high BP based on V4R3. As many
as 27% of participants with high BP based on V1R1 had
normal BP (BP , 140/90 mmHg) based on V2R3 and
36% based on V4R3. Among lower BP categories (based
on V1R1), there was also a trend toward a shift to lower
BP categories over repeated readings/visits (data not
shown in the Figure). Among subjects with BP of 140–
159/90–94 mmHg on V1R1, BP was , 140/90 mmHg in
54% on V1R3, in 80% on V2R3, and in 80% on V4R3
(7% had BP > 160/95 mmHg on V2R3 and V4R3).
Among persons with BP of 120–139/80–89 mmHg on
V1R1, BP was , 120/80 mmHg in 38% on V1R3, in
52% on V2R3, and in 61% on V4R3 (BP was > 140/
90 mmHg in 3–4% on V2R3 and V4R3).
Figure 3 shows the numbers of participants with
BP > 160/95 mmHg among all 1315 participants (re-
ferred as ‘prevalence’ in this paragraph) based on
different BP readings at different visits. The prevalence
with high BP in the sample does not represent the
prevalence in the base population since participants
were selected to include as many hypertensive as non-
hypertensive persons. However, the decrease in the
prevalence of high BP over repeated visits/readings in
the study sample is proportionate to the decrease that
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Fig. 1
Mean blood pressure (BP) and upper 95% confidence interval (CI) over repeated visits/readings. (a) Systolic BP: r, persons with systolic
BP> 160 mmHg on the first reading at the first visit (V1R1) and no hypertension treatment (n ¼ 294);j, persons under treatment on V1R1
(n ¼ 129);d, persons with systolic BP, 160 mmHg on V1R1 and no treatment (n ¼ 892). (b) Diastolic BP.r, diastolic BP> 95 mmHg on V1R1
and no treatment (n ¼ 437);j, under treatment on V1R1 (n ¼ 129); d, diastolic BP, 95 mmHg on V1R1 and no treatment (n ¼ 749).
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would have occurred in the general population over
repeated visits/readings. Compared with V1R1, the
prevalence was lower by 48% based on V2R3 and by
55% based on V4R3. The prevalence based on V2R23
or V2R3 (respectively 305 and 306 participants) was not
largely different compared with the prevalence based
on readings at the fourth visit (e.g. V4R12: 290 partici-
pants, V4R23: 253 or V4R123: 265). For example, the
prevalence based on V2R3 or V2R23 was only 21%
larger than the prevalence based on V4R23. Based on
the average of the three readings at each visit, and with
reference to readings at the first visit (V1), the pre-
valence was lower by 29% based on readings at V2 and
by 43% based on readings at V4. Hence, the prevalence
based on V2R3 or V2R23 only moderately overesti-
mated the prevalence based on readings at V4.
We then examined the association between the propor-
tionate decrease in BP and selected variables among
participants with systolic BP > 140 mmHg on V1R1
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
Table 2 Average absolute (mmHg) and proportionate decrease (%) in systolic and diastolic blood pressure over repeated readings
Difference between first and third readings at
same visits
Difference between first readings at different
visits
Units
V1R1–
V1R3y
V2R1–
V2R3
V3R1–
V3R3
V4R1–
V4R3
V1R1–
V2R1
V2R1–
V3R1
V3R1–
V4R1 Ratio{
Systolic blood pressure (SBP)
(I) SBP > 160 mmHg on V1R1 and no treatment (n ¼ 294) mmHg 11 10 7 9 13 5 3
% 6.3 6.1 4.6 5.9 7.3 2.8 1.8 0.78
(II) Under hypertension treatment (n ¼ 129) mmHg 5 6 9 7 5 1 2
% 3.0 4.4 6.0 4.7 3.1 0.7 1.3 0.78
(III) SBP , 160 mmHg on V1R1 & no treatment (n ¼ 892) mmHg 4 6 5 6 2 1 1
% 3.4 5.0 4.3 4.9 1.7 1.0 0.7 0.81
Diastolic blood pressure (DBP)
(I) DBP > 95 mmHg on V1R1 & no treatment (n ¼ 437) mmHg 6 4 4 4 7 2 1
% 5.8 4.6 3.8 4.0 6.5 1.8 1.5 0.82
(II) Under hypertension treatment (n ¼ 129) mmHg 2 3 4 4 3 1 0
% 2.1 3.5 4.7 4.7 3.0 1.5 0.4 0.75
(III) SBP , 95 mmHg on V1R1 & no treatment (n ¼ 749) mmHg 2 4 3 4 0 0 1
% 2.4 4.9 4.4 5.4 0.5 0.1 1.5 0.74
yV1R1, first reading at the first visit; V3R2, second reading at the third visit. {Ratio of the difference in BP between V1R1 and V2R3 (V1R1–V2R3) to difference in BP
between V1R1 and V4R3 (V1R1–V4R3).
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Fig. 2
Distribution (%) of selected blood pressure categories over subsequent visits/readings among persons who had BP > 160/95 mmHg on the first
reading at the first visit (n ¼ 592).
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(n ¼ 626) or diastolic BP > 90 mmHg on V1R1 (n ¼
601). The proportionate/absolute decreases between
the first and last of the 12 available readings (V1R1–
V4R3) were 14.1%/23.3 mmHg for systolic BP and
13.1%/12.6 mmHg for diastolic BP. Multivariate linear
regression (Table 3) indicated a significant inverse
association between the proportionate decrease in BP
and antihypertension treatment. A weak and less con-
sistent inverse association was found with male sex and
older age and no consistent association was found with
the wealth score. One can interpret, for example, that
the mean proportionate decrease in systolic BP be-
tween the first and last readings (V1R1–V4R3) was
smaller by 4.12% in persons under treatment compared
with persons not under treatment, independent of age,
sex, body mass index and wealth score. Overall, the
variables considered in the multivariate analyses ac-
counted for less than 5% of the variability in the
proportionate decrease of BP over repeated readings.
Discussion
This study shows that BP decreased largely within and
between visits. BP decreased substantially between the
first and third readings at each of the four visits. The
decrease was important between the first and second
visits but was small between additional visits. As a
consequence, the mean BP based on the third reading
at the second visit (V2R3) was not largely higher than
the mean BP based on the third reading at the fourth
visit (V4R3). Similarly, and with reference to the
prevalence based on the first reading at the first visit
(V1R1), the prevalence of high BP decreased by as
Copyright © Lippincott Williams & Wilkins. Unauthorized reproduction of this article is prohibited.
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Number of persons with BP> 160/95 mmHg among all study participants (n ¼ 1315) based on different visits/readings.
Table 3 Association between selected factors and proportionate percentage decrease in systolic and diastolic blood pressure over
repeated readings in participants with systolic BP> 140 mmHg (n 626) or diastolic BP> 90 (n 601) on the first reading at the first visit
Proportionate difference in BP between:
First and third readings at visit one First reading at visit one and third reading at visit four
Systolic BP R2 ¼ 0.013 Diastolic BP R2 ¼ 0.026 Systolic BP R2 ¼ 0.042 Diastolic BP R2 ¼ 0.033
 SE P  SE P  SE P  SE P
Age (10 years) 0.60 0.34 0.079 1.31 0.41 0.001 0.76 0.42 0.071 1.74 0.50 0.000
Male sex 1.45 0.76 NS 1.21 0.94 NS 2.40 0.94 0.011 1.93 1.14 0.091
Body mass index (kg/m2) 0.02 0.07 NS 0.04 0.09 NS 0.08 0.08 NS 0.11 0.10 NS
Wealth score > 4y 0.66 1.10 NS 0.11 1.36 NS 2.52 1.36 0.065 0.22 1.64 NS
On treatment for high BP 2.39 1.06 0.025 3.42 1.44 0.018 4.12 1.32 0.002 3.91 1.73 0.025
Constant 9.38 2.32 0.000 12.72 2.94 0.000 21.53 2.87 0.000 24.39 3.58 0.000
yScore ranging from 0 (lowest) to 5 (highest). BP, blood pressure.
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much as one half based on either the third reading at
the second visit (V2R3) or the last reading at the last
visit (V3R4). However, the prevalence of high BP
based on readings at the second visit (V2R3 or V2R23)
was not much higher than the prevalence based on
readings at the fourth visit (V4R3 or V4R23). Our
results suggest that the prevalence of high BP based on
repeated readings at a second visit will estimate fairly
well the true prevalence in the population. Mean BP
decreased similarly when the first three visits took
place at 3-day or 14-day intervals. This suggests that
measuring BP at two visits separated by just a few days
can capture most of the decrease of BP over repeated
visits/readings. Noticeably, the use of automatic elec-
tronic sphygmomanometers in this study prevented
several observer-related biases that can occur with
standard sphygmomanometry, including systematic er-
ror, terminal digit preference, and observer prejudice
[23].
The fall in BP over repeated readings was substantial
not only in persons with high BP, but also in subjects
with low BP. This suggests that the decrease in BP
over repeated visits relates mainly to a transient eleva-
tion of BP (defense reaction) in persons submitted to
BP measurement and only little to a regression to the
mean of high BP values. This interpretation is also
supported by the finding that the decrease was smaller
in persons under treatment, i.e. in persons who are
likely to have been more exposed to previous BP
measurements. Consistent with other reports [24], we
found that sex and age had only modest influence on
BP variability.
From a clinical perspective, substantial variability of BP
at the individual level – as apparent in our study from
only fair correlation between successive BP readings –
confirm the need to obtain multiple BP readings over
several visits to assess reliably hypertension in indi-
viduals [3,7,25]. A minimum number of visits and
readings that is sufficient for positively diagnosing
hypertension cannot be recommended, as is implicit in
current guidelines for clinical practice [11–13], since
numerous readings may be needed in some persons
before hypertension can be confirmed. However, record-
ing systematically three readings at each visit would
permit the exclusion of false-positive cases of hyper-
tension in a larger number of suspected hypertensive
persons after only one or two visits, as compared with
taking only one or two readings at each visit.
The difficulty of defining hypertension in epidemiolo-
gic studies, due to BP variability, is well recognized
[4,26,27]. The procedure used to assess the prevalence
of hypertension in populations should reliably classify
persons as hypertensive and be efficient in view of
increased costs and inconveniences associated with
repeated visits. Our study suggests that assessing the
prevalence of hypertension based on readings at a
second visit would largely avoid the overestimation of
estimates based on readings at one single screening
visit, and only slightly overestimate estimates based on
readings at more visits. To minimize the difficulties of
a strategy based on two separate visits – compared with
a strategy based on a single visit –repeated BP meas-
urements could be obtained in random sub-samples of
populations under study and appropriate adjustments
performed accordingly.
Which readings should be used when several BP meas-
urements are available from two visits? In the few
studies that have relied on BP readings obtained on
two visits, the prevalence of hypertension was often
based on the average of all readings at all visits. While
this strategy does reduce the weight of readings at the
first visit – which most overestimate a person’s true BP
– our findings suggest that prevalence estimates based
on only the third reading – or the average of the second
and third readings – at a second visit would be more
appropriate to reliably estimate the true prevalence of
hypertension in the population. A staged approach for
assessing hypertension in populations would correspond
better to the standard clinical practice whereby hyper-
tension is diagnosed only if high BP persists over
successive readings and visits. This approach would
also be consistent with JNCVI recommendations [11]
to discard screening readings and rely on readings at
subsequent visits when assessing hypertension in indi-
vidual patients.
The decline of BP with subsequent readings (i.e.
adaptation) may be, at least in part, culturally-specific,
population-specific and method-specific. For example,
one could hypothesize that the decrease of BP over
successive visits/readings would be sharper in popula-
tions with limited previous familiarization with techni-
ques and circumstances of BP measurement – such as
in Dar es Salaam – compared with western populations.
Also, less reactivity might have been observed in our
study due to the fact that the measures were taken at
home, rather than at a research office or a medical
clinic. Because the few studies that have examined this
issue have used different designs and methods, direct
comparison is difficult. However, the prevalence of
hypertension in a Canadian study in which two BP
readings were obtained at each of three visits fell by up
to one-half (i.e. as much as in our study) when follow-
up information was included [28]. In an American
study, the prevalence of hypertension decreased from
20% based on one visit to 9% based on three visits [29].
A study of 804 civil servants in Nigeria noted no greater
variability over repeated BP measurements compared
to findings in western countries [24]. In the Seychelles,
among 155 participants to a population-based survey
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who had BP > 160/95 mmHg at a first visit (based on
the average of the two last of three readings) and were
unaware of hypertension, only 50 (32%) had such high
BP at a third visit taking place within 10 days [30].
These studies suggest that the prevalence of hyper-
tension decreases largely in all populations, possibly by
more than one-half, when estimates are based on read-
ings obtained on two or more visits. A decrease of
similar magnitude over repeated visits/readings across
different populations would imply that a unique proce-
dure could be recommended for the epidemiologic
assessment of hypertension in populations. These
issues could be addressed decisively by replicating
similar systematic studies in other populations and/or
by reappraising data from the available studies along a
similar analysis protocol.
However, the large and very important literature on
morbidity and mortality associated with hypertension
has most often relied on BP based on one or two
readings at a single visit. Changing the method of
measuring BP changes the BP readings for each subject
and, consequently, will also change the cardiovascular
risk associated with definite BP levels. This issue
would deserve proper consideration through appropriate
new prospective studies of cardiovascular disease and/or
re-analysis of data in the few studies that have relied
on several BP readings/visits before recommendations
can be made on the value of BP based on subsequent
visits to predict cardiovascular events.
Our data stress the need for standard and reliable
procedures for the measurement of BP. This is true not
only in clinical practice, as generally recommended, but
also in epidemiologic studies as suggested in this study.
Our findings suggest that taking three readings on two
visits, possibly separated by just a few days, could be
an efficient strategy for reliably estimating true mean
levels of BP and prevalence of hypertension in popula-
tions. A reliable estimation of the prevalence of hyper-
tension is important for assessing the true burden of
hypertension in populations and for providing a sound
basis for control strategies, particularly in developing
countries where the burden of non-communicable dis-
eases is increasing in a context of scarce resources.
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